PhenomeX Inc. (CELL) Stock

DelistedNasdaq: CELLPhenomeX Inc.

1.00
Final close · Sep 29, 2023

CELL is no longer traded. PhenomeX was delisted from the Nasdaq in September 2023.

Prices on this page are historical; the last trade was September 29, 2023 at $1.00.

PhenomeX stock price history

Split-adjusted closes, 2020–2023

CELL final trading statistics

Final close
$1.00
Final trading day
Sep 29, 2023
Market cap at delisting
$98.79M
Shares outstanding
98.98M
Final 52-week range
$0.38 – $3.65
Avg. volume (final 3 mo.)
1,500,371
All-time high (split-adj.)
$106.00 · Dec 2020
All-time low (split-adj.)
$0.40 · Aug 2023
Return since IPO
-98.5%
Beta
0.94
Book value / share
$1.12
Price / book
0.89
Final 52 wk
0.383.65

PhenomeX earnings per share

Earnings per share

PhenomeX revenue & net income

RevenueNet income

PhenomeX annual financials

PhenomeX Inc. revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2022$78.59M-$98.0M-$1.43
FY2021$85.39M-$71.7M-$1.07
FY2020$64.30M-$41.6M-$4.75
FY2019$56.69M-$18.3M—

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About PhenomeX Inc.

PhenomeX Inc. operates as a functional cell biology company. The company enables scientists to reveal insights on cell function and obtain behavior of each cell. Its suite of tools and services offer unparalleled resolution and speed, accelerating the insights for advancing discoveries that can profoundly improve the prevention and treatment of disease. The company's platforms are used by researchers worldwide, including pharmaceutical companies and comprehensive cancer centers. PhenomeX Inc. is headquartered in Emeryville, California. As of September 29, 2023, PhenomeX Inc. operates as a subsidiary of Bruker Corporation.

PhenomeX stock FAQ

What happened to PhenomeX stock?

PhenomeX stock was delisted from the Nasdaq. Its final close was $1.00 on September 29, 2023.

Is CELL stock still trading?

No. CELL was delisted from the Nasdaq in September 2023 and no longer trades on a U.S. exchange.

What was the last price of CELL stock?

CELL closed at $1.00 on its final trading day, September 29, 2023, for a market value of about $98.79M.

What were PhenomeX's revenue and earnings in its last full fiscal year?

PhenomeX reported revenue of $78.59M and net income of -$98.0M in fiscal 2022, its last full year as a public company.

When did PhenomeX go public?

PhenomeX Inc. stock began trading on July 17, 2020.

Biotechnology stocks to research

All Healthcare stocks →